Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
- PMID: 34584244
- PMCID: PMC8477624
- DOI: 10.1038/s41422-021-00570-1
Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
Conflict of interest statement
Y.Xie, L.Z., G.X., H.J., H.E.X., G.T. and J.S. filed a patent application on antiviral nucleoside analogs.
Figures
References
-
- Butler, T., Cho, A., Kim, C. U., Saunders, O. L. & Zhang, L. WO2009132135A1 (2009).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
